{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:28:22Z","timestamp":1794360502421,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004322","name":"Shiseido Group","doi-asserted-by":"publisher","award":["JSID\u2019s Fellowship Shiseido Research Grant 2019"],"award-info":[{"award-number":["JSID\u2019s Fellowship Shiseido Research Grant 2019"]}],"id":[{"id":"10.13039\/501100004322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40257-019-00492-0","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T07:02:41Z","timestamp":1575702161000},"page":"227-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-2875","authenticated-orcid":false,"given":"Takuya","family":"Takeichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,7]]},"reference":[{"issue":"1","key":"492_CR1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2340\/00015555766871","volume":"76","author":"A Ohkawara","year":"1996","unstructured":"Ohkawara A, Yasuda H, Kobayashi H, Inaba Y, Ogawa H, Hashimoto I, et al. Generalized pustular psoriasis in Japan: two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol. 1996;76(1):68\u201371.","journal-title":"Acta Derm Venereol."},{"issue":"2","key":"492_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.17392","volume":"180","author":"L Li","year":"2019","unstructured":"Li L, You J, Fu X, Wang Z, Sun Y, Liu H, et al. Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population. Br J Dermatol. 2019;180(2):425\u20136.","journal-title":"Br J Dermatol."},{"issue":"3","key":"492_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1155\/2013\/702763","volume":"34","author":"M Yamamoto","year":"2013","unstructured":"Yamamoto M, Imai Y, Sakaguchi Y, Haneda T, Yamanishi K. Serum cytokines correlated with the disease severity of generalized pustular psoriasis. Dis Mark. 2013;34(3):153\u201361.","journal-title":"Dis Mark."},{"issue":"6","key":"492_CR4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jid.2017.12.024","volume":"138","author":"A Arakawa","year":"2018","unstructured":"Arakawa A, Vollmer S, Besgen P, Galinski A, Summer B, Kawakami Y, et al. Unopposed IL-36 activity promotes clonal CD4(+) T-cell responses with IL-17A production in generalized pustular psoriasis. J Investig Dermatol. 2018;138(6):1338\u201347.","journal-title":"J Investig Dermatol."},{"issue":"7","key":"492_CR5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620\u20138.","journal-title":"N Engl J Med."},{"issue":"3","key":"492_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","volume":"89","author":"A Onoufriadis","year":"2011","unstructured":"Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, et al. Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011;89(3):432\u20137.","journal-title":"Am J Hum Genet."},{"issue":"6","key":"492_CR7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/jid.2014.46","volume":"134","author":"K Sugiura","year":"2014","unstructured":"Sugiura K, Muto M, Akiyama M. CARD14 c.526G > C (pAsp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort. J Investig Dermatol. 2014;134(6):1755\u20137.","journal-title":"J Investig Dermatol"},{"issue":"12","key":"492_CR8","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/jid.2015.288","volume":"135","author":"DM Berki","year":"2015","unstructured":"Berki DM, Liu L, Choon SE, David Burden A, Griffiths CE, Navarini AA, et al. Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris. J Investig Dermatol. 2015;135(12):2964\u201370.","journal-title":"J Investig Dermatol."},{"issue":"4","key":"492_CR9","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/bjd.15442","volume":"177","author":"T Takeichi","year":"2017","unstructured":"Takeichi T, Kobayashi A, Ogawa E, Okuno Y, Kataoka S, Kono M, et al. Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation. Br J Dermatol. 2017;177(4):e133\u20135.","journal-title":"Br J Dermatol."},{"issue":"5","key":"492_CR10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","volume":"94","author":"N Setta-Kaffetzi","year":"2014","unstructured":"Setta-Kaffetzi N, Simpson MA, Navarini AA, Patel VM, Lu HC, Allen MH, et al. AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. Am J Hum Genet. 2014;94(5):790\u20137.","journal-title":"Am J Hum Genet."},{"issue":"6","key":"492_CR11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ijd.12070","volume":"53","author":"SE Choon","year":"2014","unstructured":"Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53(6):676\u201384.","journal-title":"Int J Dermatol."},{"issue":"4","key":"492_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/11586900-000000000-00000","volume":"12","author":"J Borges-Costa","year":"2011","unstructured":"Borges-Costa J, Silva R, Goncalves L, Filipe P, Soares de Almeida L, Marques Gomes M. Clinical and laboratory features in acute generalized pustular psoriasis: a retrospective study of 34 patients. Am J Clin Dermatol. 2011;12(4):271\u20136.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"492_CR13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.16232","volume":"178","author":"H Bachelez","year":"2018","unstructured":"Bachelez H. Pustular psoriasis and related pustular skin diseases. Br J Dermatol. 2018;178(3):614\u20138.","journal-title":"Br J Dermatol."},{"issue":"12","key":"492_CR14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","volume":"80","author":"H Baker","year":"1968","unstructured":"Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol. 1968;80(12):771\u201393.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"492_CR15","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00403-002-0371-6","volume":"295","author":"Y Umezawa","year":"2003","unstructured":"Umezawa Y, Ozawa A, Kawasima T, Shimizu H, Terui T, Tagami H, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res. 2003;295(Suppl 1):S43\u201354.","journal-title":"Arch Dermatol Res."},{"issue":"1","key":"492_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-263X.2006.00674.x","volume":"16","author":"DL Furlanetto","year":"2006","unstructured":"Furlanetto DL, Crighton A, Topping GV. Differences in methodologies of measuring the prevalence of oral mucosal lesions in children and adolescents. Int J Paediatr Dent. 2006;16(1):31\u20139.","journal-title":"Int J Paediatr Dent."},{"issue":"2","key":"492_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00439-016-1750-y","volume":"136","author":"J Liang","year":"2017","unstructured":"Liang J, Huang P, Li H, Zhang J, Ni C, Wang Y, et al. Mutations in IL36RN are associated with geographic tongue. Hum Genet. 2017;136(2):241\u201352.","journal-title":"Hum Genet."},{"issue":"12","key":"492_CR18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/1346-8138.13724","volume":"44","author":"J Knuever","year":"2017","unstructured":"Knuever J, Tantcheva-Poor I. Generalized pustular psoriasis: a possible association with severe hypocalcaemia due to primary hypoparathyroidism. J Dermatol. 2017;44(12):1416\u20137.","journal-title":"J Dermatol."},{"issue":"3","key":"492_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000442380","volume":"7","author":"CA Guerreiro de Moura","year":"2015","unstructured":"Guerreiro de Moura CA, de Assis LH, Goes P, Rosa F, Nunes V, Gusmao IM, et al. A case of acute generalized pustular psoriasis of von Zumbusch triggered by hypocalcemia. Case Rep Dermatol. 2015;7(3):345\u201351.","journal-title":"Case Rep Dermatol"},{"issue":"11","key":"492_CR20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/1346-8138.14523","volume":"45","author":"H Fujita","year":"2018","unstructured":"Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45(11):1235\u201370.","journal-title":"J Dermatol."},{"issue":"3","key":"492_CR21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","volume":"143","author":"S Twelves","year":"2019","unstructured":"Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143(3):1021\u20136.","journal-title":"J Allergy Clin Immunol."},{"issue":"31","key":"492_CR22","doi-asserted-by":"crossref","first-page":"e11741","DOI":"10.1097\/MD.0000000000011741","volume":"97","author":"Z Li","year":"2018","unstructured":"Li Z, Yang Q, Wang S. Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: a case\u2013control study. Medicine (Baltimore). 2018;97(31):e11741.","journal-title":"Medicine (Baltimore)."},{"issue":"11","key":"492_CR23","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/jid.2013.230","volume":"133","author":"K Sugiura","year":"2013","unstructured":"Sugiura K, Takemoto A, Yamaguchi M, Takahashi H, Shoda Y, Mitsuma T, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Investig Dermatol. 2013;133(11):2514\u201321.","journal-title":"J Investig Dermatol."},{"issue":"1","key":"492_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdermsci.2016.10.009","volume":"85","author":"T Takeichi","year":"2017","unstructured":"Takeichi T, Togawa Y, Okuno Y, Taniguchi R, Kono M, Matsue H, et al. A newly revealed IL36RN mutation in sibling cases complements our IL36RN mutation statistics for generalized pustular psoriasis. J Dermatol Sci. 2017;85(1):58\u201360.","journal-title":"J Dermatol Sci."},{"issue":"3","key":"492_CR25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bjd.15867","volume":"178","author":"R Mossner","year":"2018","unstructured":"Mossner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Lohr S, Schulz P, et al. The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol. 2018;178(3):740\u20138.","journal-title":"Br J Dermatol."},{"issue":"3","key":"492_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.det.2013.04.005","volume":"31","author":"SV Tripathi","year":"2013","unstructured":"Tripathi SV, Leslie KS. Autoinflammatory diseases in dermatology: CAPS, TRAPS, HIDS, FMF, Blau CANDLE. Dermatol Clin. 2013;31(3):387\u2013404.","journal-title":"Dermatol Clin."},{"issue":"12","key":"492_CR27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1600-0560.2010.01612.x","volume":"37","author":"SH Kardaun","year":"2010","unstructured":"Kardaun SH, Kuiper H, Fidler V, Jonkman MF. The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol. 2010;37(12):1220\u20139.","journal-title":"J Cutan Pathol."},{"issue":"4","key":"492_CR28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamadermatol.2014.3848","volume":"151","author":"AA Navarini","year":"2015","unstructured":"Navarini AA, Simpson MA, Borradori L, Yawalkar N, Schlapbach C. Homozygous missense mutation in IL36RN in generalized pustular dermatosis with intraoral involvement compatible with both AGEP and generalized pustular psoriasis. JAMA Dermatol. 2015;151(4):452\u20133.","journal-title":"JAMA Dermatol."},{"issue":"4","key":"492_CR29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1744-9987.12342","volume":"19","author":"T Fujisawa","year":"2015","unstructured":"Fujisawa T, Suzuki S, Mizutani Y, Doi T, Yoshida S, Ogura S, et al. Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis: therapeutic outcomes in three refractory patients. Ther Apher Dial. 2015;19(4):336\u201341.","journal-title":"Ther Apher Dial"},{"issue":"9","key":"492_CR30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/1346-8138.13306","volume":"43","author":"S Imafuku","year":"2016","unstructured":"Imafuku S, Honma M, Okubo Y, Komine M, Ohtsuki M, Morita A, et al. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: a 52-week analysis from phase III open-label multicenter Japanese study. J Dermatol. 2016;43(9):1011\u20137.","journal-title":"J Dermatol."},{"issue":"2","key":"492_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jdv.15287","volume":"33","author":"Y Okubo","year":"2019","unstructured":"Okubo Y, Mabuchi T, Iwatsuki K, Elmaraghy H, Torisu-Itakura H, Morisaki Y, et al. Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J). J Eur Acad Dermatol Venereol. 2019;33(2):325\u201332.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"3","key":"492_CR32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjd.14702","volume":"176","author":"K Yamasaki","year":"2017","unstructured":"Yamasaki K, Nakagawa H, Kubo Y, Ootaki K, Japanese Brodalumab Study G. Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study. Br J Dermatol. 2017;176(3):741\u201351.","journal-title":"Br J Dermatol"},{"issue":"12","key":"492_CR33","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/1346-8138.14664","volume":"45","author":"A Morita","year":"2018","unstructured":"Morita A, Yamazaki F, Matsuyama T, Takahashi K, Arai S, Asahina A, et al. Adalimumab treatment in Japanese patients with generalized pustular psoriasis: results of an open-label phase 3 study. J Dermatol. 2018;45(12):1371\u201380.","journal-title":"J Dermatol."},{"issue":"5","key":"492_CR34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/1346-8138.14294","volume":"45","author":"S Sano","year":"2018","unstructured":"Sano S, Kubo H, Morishima H, Goto R, Zheng R, Nakagawa H. Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study. J Dermatol. 2018;45(5):529\u201339.","journal-title":"J Dermatol."},{"issue":"4","key":"492_CR35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000117706","volume":"216","author":"M Esposito","year":"2008","unstructured":"Esposito M, Mazzotta A, Casciello C, Chimenti S. Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series. Dermatology. 2008;216(4):355\u201360.","journal-title":"Dermatology."},{"issue":"4","key":"492_CR36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.0906-6705.2004.00205.x","volume":"13","author":"AJ Schottelius","year":"2004","unstructured":"Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK 3rd. Biology of tumor necrosis factor-alpha-implications for psoriasis. Exp Dermatol. 2004;13(4):193\u2013222.","journal-title":"Exp Dermatol."},{"issue":"10","key":"492_CR37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/exd.13699","volume":"27","author":"A Boehner","year":"2018","unstructured":"Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis\u2014a model disease for specific targeted immunotherapy, systematic review. Exp Dermatol. 2018;27(10):1067\u201377.","journal-title":"Exp Dermatol."},{"issue":"6","key":"492_CR38","first-page":"e652","volume":"8","author":"SK Saikaly","year":"2016","unstructured":"Saikaly SK, Mattes M. Biologics and pediatric generalized pustular psoriasis: an emerging therapeutic trend. Cureus. 2016;8(6):e652.","journal-title":"Cureus."},{"issue":"5","key":"492_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1203475418758986","volume":"22","author":"D Almutairi","year":"2018","unstructured":"Almutairi D, Sheasgreen C, Weizman A, Alavi A. Generalized pustular psoriasis induced by infliximab in a patient with inflammatory bowel disease. J Cutan Med Surg. 2018;22(5):507\u201310.","journal-title":"J Cutan Med Surg."},{"issue":"12","key":"492_CR40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/2013.jamadermatol.80","volume":"148","author":"M Viguier","year":"2012","unstructured":"Viguier M, Aubin F, Delaporte E, Pages C, Paul C, Beylot-Barry M, et al. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis. Arch Dermatol. 2012;148(12):1423\u20135.","journal-title":"Arch Dermatol."},{"issue":"7","key":"492_CR41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/1346-8138.14318","volume":"45","author":"D Wilsmann-Theis","year":"2018","unstructured":"Wilsmann-Theis D, Schnell LM, Ralser-Isselstein V, Bieber T, Schon MP, Huffmeier U, et al. Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations. J Dermatol. 2018;45(7):850\u20134.","journal-title":"J Dermatol."},{"issue":"10","key":"492_CR42","first-page":"1133","volume":"14","author":"E Lee","year":"2015","unstructured":"Lee E, Zarei M, LaSenna C, Villada G, Romanelli P. Psoriasis targeted therapy: characterization of interleukin 17A expression in subtypes of psoriasis. J Drugs Dermatol. 2015;14(10):1133\u20136.","journal-title":"J Drugs Dermatol."},{"issue":"10","key":"492_CR43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1811317","volume":"380","author":"H Bachelez","year":"2019","unstructured":"Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med. 2019;380(10):981\u20133.","journal-title":"N Engl J Med."},{"issue":"14","key":"492_CR44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1806382","volume":"379","author":"K Papp","year":"2018","unstructured":"Papp K, Gordon K, Thaci D, Morita A, Gooderham M, Foley P, et al. Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis. N Engl J Med. 2018;379(14):1313\u201321.","journal-title":"N Engl J Med."},{"issue":"6","key":"492_CR45","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","volume":"140","author":"M Akiyama","year":"2017","unstructured":"Akiyama M, Takeichi T, McGrath JA, Sugiura K. Autoinflammatory keratinization diseases. J Allergy Clin Immunol. 2017;140(6):1545\u20137.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"492_CR46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","volume":"90","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Takeichi T, McGrath JA, Sugiura K. Autoinflammatory keratinization diseases: an emerging concept encompassing various inflammatory keratinization disorders of the skin. J Dermatol Sci. 2018;90(2):105\u201311.","journal-title":"J Dermatol Sci."},{"issue":"4","key":"492_CR47","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1111\/1346-8138.14666","volume":"46","author":"T Takeichi","year":"2019","unstructured":"Takeichi T, Akiyama M. Familial or sporadic porokeratosis as an autoinflammatory keratinization disease. J Dermatol. 2019;46(4):e125\u20136.","journal-title":"J Dermatol."},{"issue":"2","key":"492_CR48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdermsci.2018.01.017","volume":"90","author":"R Oi","year":"2018","unstructured":"Oi R, Takeichi T, Okuno Y, Kojima D, Sugawara K, Kono M, et al. An infant with generalized pustular psoriasis and geographic tongue had a heterozygous IL36RN mutation and IgG2 deficiency. J Dermatol Sci. 2018;90(2):216\u20138.","journal-title":"J Dermatol Sci."},{"issue":"2","key":"492_CR49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaci.2018.11.009","volume":"143","author":"M Akiyama","year":"2019","unstructured":"Akiyama M. Early-onset generalized pustular psoriasis is representative of autoinflammatory keratinization diseases. J Allergy Clin Immunol. 2019;143(2):809\u201310.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"492_CR50","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/jid.2012.490","volume":"133","author":"N Setta-Kaffetzi","year":"2013","unstructured":"Setta-Kaffetzi N, Navarini AA, Patel VM, Pullabhatla V, Pink AE, Choon SE, et al. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Investig Dermatol. 2013;133(5):1366\u20139.","journal-title":"J Investig Dermatol."},{"issue":"10","key":"492_CR51","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","volume":"32","author":"KM Hoegler","year":"2018","unstructured":"Hoegler KM, John AM, Handler MZ, Schwartz RA. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol. 2018;32(10):1645\u201351.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"492_CR52","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaci.2014.09.043","volume":"135","author":"S Hussain","year":"2015","unstructured":"Hussain S, Berki DM, Choon SE, Burden AD, Allen MH, Arostegui JI, et al. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol. 2015;135(4):1067\u201370.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"492_CR53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamadermatol.2016.0751","volume":"152","author":"A Arakawa","year":"2016","unstructured":"Arakawa A, Ruzicka T, Prinz JC. Therapeutic efficacy of interleukin 12\/interleukin 23 blockade in generalized pustular psoriasis regardless of IL36RN mutation status. JAMA Dermatol. 2016;152(7):825\u20138.","journal-title":"JAMA Dermatol."},{"issue":"1","key":"492_CR54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","volume":"140","author":"A Johnston","year":"2017","unstructured":"Johnston A, Xing X, Wolterink L, Barnes DH, Yin Z, Reingold L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109\u201320.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"492_CR55","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.4049\/jimmunol.1801519","volume":"202","author":"JJ Campbell","year":"2019","unstructured":"Campbell JJ, Ebsworth K, Ertl LS, McMahon JP, Wang Y, Yau S, et al. Efficacy of chemokine receptor inhibition in treating IL-36alpha-induced psoriasiform inflammation. J Immunol. 2019;202(6):1687\u201392.","journal-title":"J Immunol."},{"issue":"5","key":"492_CR56","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, Cao L, Roberson ED, Pierson KC, Yang CF, Joyce CE, et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet. 2012;90(5):784\u201395.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"492_CR57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","volume":"91","author":"D Fuchs-Telem","year":"2012","unstructured":"Fuchs-Telem D, Sarig O, van Steensel MA, Isakov O, Israeli S, Nousbeck J, et al. Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet. 2012;91(1):163\u201370.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"492_CR58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamadermatol.2016.3601","volume":"153","author":"T Takeichi","year":"2017","unstructured":"Takeichi T, Sugiura K, Nomura T, Sakamoto T, Ogawa Y, Oiso N, et al. Pityriasis rubra pilaris type V as an autoinflammatory disease by CARD14 mutations. JAMA Dermatol. 2017;153(1):66\u201370.","journal-title":"JAMA Dermatol."},{"issue":"6","key":"492_CR59","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1096\/fj.201802090RR","volume":"33","author":"S Shao","year":"2019","unstructured":"Shao S, Fang H, Zhang J, Jiang M, Xue K, Ma J, et al. Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes. FASEB J. 2019;33(6):6813\u201328.","journal-title":"FASEB J."},{"issue":"11","key":"492_CR60","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.jid.2016.06.618","volume":"136","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Twelves S, Farkas K, Setta-Kaffetzi N, Burden AD, Gach JE, et al. AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production. J Investig Dermatol. 2016;136(11):2251\u20139.","journal-title":"J Investig Dermatol."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00492-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:09:48Z","timestamp":1695496188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00492-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,7]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00492-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,7]]},"assertion":[{"value":"7 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Japanese Society for Investigative Dermatology (JSID) Fellowship Shiseido Research Grant 2019 to TT.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Takuya Takeichi and Masashi Akiyama have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}